These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2475684)

  • 1. The effects of slow-release verapamil on blood pressure and cardiovascular system in essential hypertension.
    Meric M; Adalet K; Erzengin F; Korkut F; Okur O; Büyüköztürk K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S42-4. PubMed ID: 2475684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
    White WB; Sica DA; Calhoun D; Mansoor GA; Anders RJ
    Am Heart J; 2002 Oct; 144(4):657-65. PubMed ID: 12360162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
    Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
    Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mild to moderate hypertension with verapamil slow-release in outpatients. Collaborative Group of the Spanish League for the Fight Against Hypertension.
    Gómez Pajuelo C; Pérez Naranjo J; Ruiz Martínez I
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S50-2. PubMed ID: 2475687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB; Black HR; Weber MA; Elliott WJ; Bryzinski B; Fakouhi TD
    Am J Cardiol; 1998 Feb; 81(4):424-31. PubMed ID: 9485131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled study on the treatment of hypertension with verapamil in retard form].
    Belz GG; Spies G
    Z Kardiol; 1985 Aug; 74(8):453-9. PubMed ID: 3901562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel delivery system for verapamil designed to achieve maximal blood pressure control during the early morning.
    Neutel JM; Alderman M; Anders RJ; Weber MA
    Am Heart J; 1996 Dec; 132(6):1202-6. PubMed ID: 8969572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twice-daily administration of oral verapamil in the treatment of essential hypertension.
    Frishman W; Charlap S; Kimmel B; Saltzberg S; Stroh J; Weinberg P; Monuszko E; Wiezner J; Dorsa F; Pollack S
    Arch Intern Med; 1986 Mar; 146(3):561-5. PubMed ID: 3954530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of slow-release verapamil and nitrendipine on office and 24-hour ambulatory blood pressure in hypertensive patients.
    Pannarale G; Puddu PE; Campbell SV; Collauto F; Stazi F; Reale A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S53-6. PubMed ID: 1377307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
    Bakris G; Sica D; Ram V; Fagan T; Vaitkus PT; Anders RJ
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):53-7. PubMed ID: 11824861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy.
    White WB; Johnson MF; Black HR; Elliott WJ; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1239-47. PubMed ID: 11775133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.
    Nissinen A; Koistinen A; Tuomilehto J; Sundberg S; Gordin A
    Eur J Clin Pharmacol; 1986; 31(3):255-9. PubMed ID: 3539623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness.
    Novo S; Alaimo G; Abrignani MG; Longo B; Muratore G; Strano A
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S38-41. PubMed ID: 2475683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy and tolerability of enalapril and slow-release verapamil in essential hypertension: a double-blind, cross-over study.
    Fagher B; Katzman P; Hulthén UL; Henningsen NC; Thulin T
    J Intern Med; 1991 Sep; 230(3):219-26. PubMed ID: 1895044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of verapamil SR 240 mg in essential hypertension: results of a multicentric phase IV study.
    Speders S; Sosna J; Schumacher A; Pfennigsdorf G
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S47-9. PubMed ID: 2475686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating hypertension in black compared with white non-insulin dependent diabetics: a double blind trial of verapamil and metoprolol.
    Cruickshank JK; Anderson NM; Wadsworth J; Young SM; Jepson E
    BMJ; 1988 Nov; 297(6657):1155-9. PubMed ID: 3144329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.